QA: Celgene CORP DE in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000816284_2015_Celgene_CORP_DE.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000816284, Celgene CORP DE

  xvar xval
0 AssetsCurrent 9,712,600,000
1 IntangibleAssetsNetIncludingGoodwill 6,258,800,000
2 PropertyPlantAndEquipmentNet 642,600,000
3 remainder_Assets 726,100,000
4 LiabilitiesCurrent 2,112,200,000
5 LiabilitiesNoncurrent 7,846,800,000
6 remainder_Liabilities 856,300,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,116,603,587
9 ResearchAndDevelopmentExpense 2,460,704,905
10 remainder_Expenses 1,261,750,336
11 remainder_Revenues 7,969,126,490
12 remainder_NetIncome -25,002,867
13 remainder_ComprehensiveNetIncome 4,205,746,593
  yvar yval
0 Assets 17,340,100,000
1 Liabilities 10,815,300,000
2 Expenses 5,839,058,828
3 Revenues 7,969,126,490
4 StockholdersEquity 6,524,800,000
5 NetIncome 2,105,064,795
6 ComprehensiveNetIncome 4,207,938,092
7 BaseVar 23,097,167,389
8 EconomicCapitalRatiobeforeLimitedLiability 1.31
9 EconomicCapitalRatio 2.54

Edgar->Model Mapping

Feature Distribution

Change over Time